We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:3423P
GW Pharmaceuticals PLC
05 March 2008
5 March 2008
GW Pharmaceuticals plc
("GW" or "the Company")
APPOINTMENT OF COMPANY SECRETARY
GW Pharmaceuticals plc (AIM: GWP) announces that Adam George BSc, ACA has been
appointed as Company Secretary and Financial Controller. He takes over from
Jonathan Laughton who is leaving to devote time to other business interests.
Adam has been working alongside Jonathan since mid 2007 so as to ensure a smooth
transition. We thank Jonathan for his significant contribution to GW over the
last 8 years.
Enquiries:
GW Pharmaceuticals plc
01980 557000
Justin Gover, Managing Director
David Kirk, Finance Director
This information is provided by RNS
The company news service from the London Stock Exchange
END
COSEALDLESNPEFE
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
